// App-Quantinova.ai

403 : Performance assessment of highly sensitive NGS assay for TP53

Researchers

Presenter

  • Johannes Fredebohm

Principal Investigators

  • Daniel Mehnert

  • Ann-Kathrin Lober

  • Hiroyuki Shimizu

  • Frank Holtrup

  • Frank Diehl

Medical Centers

  • Sysmex Inostics GmbH, Hamburg, Germany

  • Sysmex Corporation, Kobe, Japan

Locations

  • Germany

  • Japan

Companies

  • Sysmex Inostics GmbH

  • Sysmex Corporation

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved